Lyme disease vaccine: Valneva announces collaboration with Pfizer
by Press Release from Outbreak News Today on (#52WF3)
Valneva SE, a specialty vaccine company, and Pfizer Inc. today announced a collaboration to develop and commercialize Valneva's Lyme disease vaccine candidate VLA15, which is currently in Phase 2 clinical studies. VLA15 is the only active Lyme disease vaccine program in clinical development today, and covers six serotypes that are prevalent in North America and [...]
The post Lyme disease vaccine: Valneva announces collaboration with Pfizer appeared first on Outbreak News Today.